BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 9292750)

  • 21. [Radionuclides, technologies and quality control in brachytherapy].
    Marchesi V; Gautier M; Villani N; Feuillade J; Dejean C
    Cancer Radiother; 2013 Apr; 17(2):85-8. PubMed ID: 23474213
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Dosimetric study of a gynecologic applicator for cobalt 60 sources, using a computer].
    Randaccio P; Sanna R
    Radiol Med; 1978 Feb; 64(2):147-52. PubMed ID: 684254
    [No Abstract]   [Full Text] [Related]  

  • 23. A comprehensive dosimetric comparison between (131)Cs and (125)I brachytherapy sources for COMS eye plaque implant.
    Zhang H; Martin D; Chiu-Tsao ST; Meigooni A; Thomadsen BR
    Brachytherapy; 2010; 9(4):362-72. PubMed ID: 20116342
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The treatment of patients with cancer of the corpus uteri using the gamma emitter 137Cs].
    Chernichenko VA; Ivankova VS; Demina EA; Zlochevskaia LL
    Vrach Delo; 1991 Dec; (12):81-3. PubMed ID: 1792785
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A general formula for computation of tissue-air ratios for radionuclides commonly used in brachytherapy.
    Tripathi UB; Shanta A
    Med Phys; 1985; 12(1):88-9. PubMed ID: 3974531
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Relation of the dosage from point-shaped 192Ir sources to angle and its effect on dosage in different irradiation plans in afterloading therapy].
    Günther R; Walter W; Kob D; Kloetzer KH
    Radiobiol Radiother (Berl); 1985; 26(3):277-88. PubMed ID: 4059515
    [No Abstract]   [Full Text] [Related]  

  • 27. [Initial experiences with radiation planning of combined teletherapy and brachytherapy of gynecologic tumors using CT tomograms].
    Schmidt KP; Bolck M; Holtzhauer R; Tabbert E
    Radiobiol Radiother (Berl); 1990; 31(4):361-71. PubMed ID: 2236524
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Methods of dose distribution formation during intracavitary gamma therapy].
    Sul'kin AG; Titova VA; Sokolov VG; Batner AA
    Med Radiol (Mosk); 1984 May; 29(5):67-71. PubMed ID: 6727604
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Solid state TL detectors for in vivo dosimetry in brachytherapy.
    Gambarini G; Borroni M; Grisotto S; Maucione A; Cerrotta A; Fallai C; Carrara M
    Appl Radiat Isot; 2012 Dec; 71 Suppl():48-51. PubMed ID: 22920417
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Calculation of doses in intracavitary therapy.
    Stanef I; Oncescu M
    Int J Nucl Med Biol; 1983; 10(2-3):133-6. PubMed ID: 6642889
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Retrospective analysis of multi-institutional, patient-specific treatment planning results of high-dose-rate intracavitary brachytherapy for gynecological cancer using V
    Watanabe T; Miyashita H; Notake R; Todoroki K; Nakajima G; Washizu K; Utsumi N; Hatanaka S; Hariu M; Yamano T; Nishimura K; Shimbo M; Takahashi T
    Australas Phys Eng Sci Med; 2018 Dec; 41(4):1069-1074. PubMed ID: 30361917
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An optimization method for reference dose point of rectum in brachytherapy of gynecological neoplasms.
    Güden M; Ulutin C; Dede M; Dilek S; Pak Y
    Tohoku J Exp Med; 2002 May; 197(1):35-40. PubMed ID: 12180791
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Current possibilities of utilizing covert sources of radiation in brachytherapy for neoplasia].
    Kanaev SV; Turkevich VG
    Vopr Onkol; 2007; 53(6):690-5. PubMed ID: 18416139
    [No Abstract]   [Full Text] [Related]  

  • 34. [Interstitial gamma therapy using automated remote-control positioning of radiation sources in the treatment of malignant vaginal and vulvar neoplasms].
    Nechushkin MI; Mar'ina LA; Uĭmanov VA; Riabtseva AM
    Vopr Onkol; 1998; 44(5):599-603. PubMed ID: 9884724
    [No Abstract]   [Full Text] [Related]  

  • 35. Clinical and dosimetric factors associated with acute rectal toxicity in patients treated with (131)Cs brachytherapy for prostate cancer.
    Gokhale AS; Beriwal S; Smith RP; Li X; Benoit R
    Brachytherapy; 2010; 9(4):328-34. PubMed ID: 20116341
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Real-time dose-rate monitoring with gynecologic brachytherapy: Results of an initial clinical trial.
    Belley MD; Craciunescu O; Chang Z; Langloss BW; Stanton IN; Yoshizumi TT; Therien MJ; Chino JP
    Brachytherapy; 2018; 17(6):1023-1029. PubMed ID: 30150015
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Measurement of the distance of the rectal mucosa from a gynecologic afterloading applicator based on the drop in performance of a cobalt-60-source].
    Schrader R; Bahnsen J; Schrader D; Frischbier HJ
    Strahlenther Onkol; 1994 Feb; 170(2):103-6. PubMed ID: 8108775
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gynecological brachytherapy for postoperative endometrial cancer: dosimetric analysis (Ir-192 vs Co-60).
    Tormo Ferrero V; Duque Ugarte R; Berenguer Francés MÁ; Cardenal Maciá R
    Clin Transl Oncol; 2017 Nov; 19(11):1409-1413. PubMed ID: 28516398
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Experimental verification of cesium brachytherapy line source emission using a semiconductor detector.
    Metcalfe PE
    Med Phys; 1988; 15(5):702-6. PubMed ID: 3185405
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dosimetric consequences of asymmetric positioning of active source in 137 Cs and 226Ra intracavitary tubes.
    Sharma SC; Williamson JF; Khan FM; Jones TK
    Int J Radiat Oncol Biol Phys; 1981 Apr; 7(4):555-9. PubMed ID: 7251424
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.